Related Experiment Video
Updated: Feb 5, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3
Xuanxuan Dai1, Changtian Yin1, Guilong Guo2
1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Abstract:
Triple negative breast cancer (TNBC) is an aggressive subgroup of human breast cancer. In this study, we have examined the potential of Schisandrin B (Sch B), a bioactive chemical compound found in Schisandra chinensis, against TNBC. We used MDA-MB-231, BT-549, and MDA-MB-468 TNBC cells and immunodeficient mice to study the effect of Sch B. Our results show that Sch B inhibits TNBC growth by inducing cell cycle arrest and by triggering apoptotic death. Sch B also inhibited the migration and colony formation of tumor cells, and prevented the growth of TNBC cells in mice. We found that these inhibitory activities were mediated through suppression of signal transducer and activator of transcription-3 (STAT3) phosphorylation and nuclear translocation. Taken together, our studies show that Sch B has potent anti-tumor activity against TNBC via a novel mechanism involving STAT3 inactivation.
Insights
Schisandrin B (Sch B) effectively inhibits aggressive triple-negative breast cancer (TNBC) growth by inducing cell death and halting tumor progression. This compound shows potent anti-tumor activity via STAT3 pathway inactivation.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited treatment options.
- Schisandrin B (Sch B) is a bioactive compound derived from Schisandra chinensis with potential therapeutic properties.
Purpose of the Study:
- To investigate the anti-tumor effects of Schisandrin B (Sch B) on triple-negative breast cancer (TNBC).
- To elucidate the underlying molecular mechanisms of Sch B's action against TNBC.
Main Methods:
- In vitro studies using TNBC cell lines (MDA-MB-231, BT-549, MDA-MB-468).
- In vivo studies using immunodeficient mice xenograft models.
- Analysis of cell cycle arrest, apoptosis, migration, and colony formation.
- Assessment of signal transducer and activator of transcription-3 (STAT3) phosphorylation and nuclear translocation.
Main Results:
- Schisandrin B significantly inhibited TNBC cell proliferation, migration, and colony formation.
- Sch B induced cell cycle arrest and promoted apoptotic cell death in TNBC cells.
- The anti-tumor effects of Sch B were associated with the suppression of STAT3 phosphorylation and nuclear translocation.
- Sch B demonstrated efficacy in preventing TNBC tumor growth in vivo.
Conclusions:
- Schisandrin B exhibits potent anti-tumor activity against triple-negative breast cancer.
- Sch B exerts its effects through the induction of cell cycle arrest, apoptosis, and inhibition of cell migration.
- The novel mechanism involves the inactivation of the STAT3 signaling pathway, highlighting Sch B as a potential therapeutic agent for TNBC.
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Negative Regulator Molecules
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Positive, Negative, and Zero Work
Enzyme Inhibition

